Core Viewpoint - Lumexa Imaging, a provider of outpatient imaging diagnostic services, has successfully launched on the US stock market with an opening price of $18.8, slightly above its IPO price of $18.5 [1] Company Overview - Lumexa Imaging is headquartered in North Carolina and operates 184 diagnostic centers across 13 states in the US [1] - The company was founded in 2018 by Charlotte Radiology and investment firm Welsh, Carson, Anderson & Stowe, starting with only 20 centers [1] - Lumexa Imaging has expanded through 20 acquisitions and the establishment of 41 new locations [1] Services Offered - The company provides a range of advanced and routine imaging services, including MRI, CT, PET, X-ray, ultrasound, and mammography [1] Network and Partnerships - Lumexa Imaging has developed a diversified referral network, collaborating with over 29,000 healthcare institutions and approximately 100,000 physicians [1] Financial Performance - The company reported a sales figure of $1 billion for the 12 months ending September 30, 2025 [1]

Core Viewpoint - Lumexa Imaging Holdings, a provider of outpatient imaging diagnostic services in the U.S., announced its initial public offering (IPO) terms, aiming to raise $463 million by offering 25 million shares at a price range of $17-20 per share [1] Company Overview - Lumexa Imaging is headquartered in North Carolina and operates 184 diagnostic centers across 13 states in the U.S. through wholly-owned operations and joint ventures with healthcare systems [1] - The company offers a range of advanced and routine imaging services, including MRI, CT, PET, X-ray, ultrasound, and mammography [1] - Founded in 2018 by Charlotte Radiology and investment firm Welsh, Carson, Anderson & Stowe, Lumexa started with only 20 centers and has expanded through 20 acquisitions and the opening of 41 new locations [1] Business Network and Financials - Lumexa Imaging has established a diversified referral network, collaborating with over 29,000 healthcare providers and employing approximately 100,000 individuals [1] - The company reported sales of $1 billion for the 12 months ending September 30, 2025 [1]